Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

38.47 USD +0.31 (+0.81%)
Official Closing Price Updated: 7:51 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
U.S. doctors, hospitals reap $6.5 bln from drug and device makers -report
June 30 (Reuters) - U.S. doctors and research hospitals collected nearly $6.5 billion in payments for services rendered to pharmaceutical and medical device companies in 2014, according to the Centers... 
Tags companyNews
From Reuters: Company News
Scientists crack gene secret that lets poppies make morphine
LONDON, June 25 (Reuters) - Scientists have identified a key gene used by poppies to make morphine, paving the way for better methods of producing the medically important drug, potentially without the... 
Tags companyNews
From Reuters: Company News
London mayor suggests $15 bln 'megafund' to boost biotech
LONDON, June 25 (Reuters) - Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) "megafund" to help biotech firms in London and across Britain compete... 
Tags companyNews
From Reuters: Company News
U.S. CDC updates recommendation for new meningitis B vaccines
June 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23... 
Tags companyNews
From Reuters: Company News
The Stock Whisper Of The Day: SFUN, F, XLF, GSK
Hot stocks of the day: SFUN, F, XLF, GSK 
Tags Stocks / Equities
From Blogs - TalkMarkets
Relief Rally
European companies hoarded cash, now an average of about 4.5% in the balance sheet of large companies across the pond. Meanwhile US multinational companies have run their cash down to 2% despite low... 
Tags Stocks / Equities
From Blogs - TalkMarkets
PRESS DIGEST- British Business - June 23
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
February 2016 Options Now Available For GlaxoSmithKline (GSK)
Investors in GlaxoSmithKline plc (GSK) saw new options become available today, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the... 
Tags Stocks
From Market News Video
5 NYSE Healthcare Stocks With The Highest ROE
Below are the top NYSE stocks in the healthcare sector in terms of return on equity. The trailing-twelve-month return on equity ... 
Tags NVO HLS Trading Ideas
From Benzinga
Ben Franklin And Pope Francis
Teva now has gobbled up 4.6% of the outstanding shares of Mylan which will give it "standing" under Dutch law to call for a shareholders' vote on a takeover bid. 
Tags Technology Stocks / Equities Basic Materials / Commodities
From Blogs - TalkMarkets
Early movers: CI, WMB, PFE, ALL, AAPL & more
These are the stocks posting the largest moves before the bell. 
Tags The Priceline Group Microsoft Corp Business/Earnings
From CNBC.com News
GSK sells two vaccines to Pfizer to ease competition concerns
LONDON, June 22 (Reuters) - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis. 
Tags companyNews
From Reuters: Company News
Buying Stock While In Acats
My newest stock pick has had me on tenterhooks for a week and inevitably the price rose while I waited to be able to trade, luckily not too much. The share was beaten down because its industry was hit... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Chardan: Sell Axovant Sciences, RVT-101 Market Pricing Is 'Highly Irrational'
In a report published Thursday, Chardan Capital analyst Gbola Amusa initiated coverage of Axovant Sciences Ltd (NYSE: AXON) with a Sell ... 
Tags Chardan Capital Markets Analyst Color AXON
From Benzinga
Jim Cramer Advises His Viewers On GlaxoSmithKline, American International Group, Caesars And Caesars Acquisition
On CNBC's Mad Money, Jim Cramer said that GlaxoSmithKline plc (ADR) (NYSE: GSK) is not doing well. He can't recommend it and he would ... 
Tags Jim Cramer CNBC WFC
From Benzinga
UK investigator says Chinese officials mistreated him to get GSK confession
LONDON/BEIJING, June 18 (Reuters) - A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to... 
Tags companyNews
From Reuters: Company News
How to Forecast Pharma Stocks (PFE, RAD, JNJ)
 
Tags NYSE:MRK Financial Advisor Center NYSE:RAD
From InvestorPlace
GSK invests $95 mln in effort to demystify cell 'operating system'
LONDON, June 17 (Reuters) - British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating... 
Tags companyNews
From Reuters: Company News
U.S. top court rejects Iraq bid to revive 'oil-for-food' lawsuit
WASHINGTON, June 15 (Reuters) - The U.S. Supreme Court on Monday rejected an effort by Iraq to revive a lawsuit against dozens of companies for allegedly conspiring with former leader Saddam Hussein's... 
Tags companyNews
From Reuters: Company News
Why no MERS vaccine? Lack of foresight frustrates scientists
LONDON, June 15 (Reuters) - Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for not having a vaccine that could have protected... 
Tags companyNews
From Reuters: Company News
Axovant Sciences' IPO Sparks Comment On 'Biotech Bubble'
Axovant Sciences Ltd (NYSE: AXON) nearly doubled during its first few hours of trading Thursday, stirring comments about a biotech ... 
Tags GSK IPOs Harvard College
From Benzinga
Axovant Sciences (AXON) Stock Reeks to High Heaven
 
Tags Stocks to Sell NYSE:AXON NASDAQ:TKMR
From InvestorPlace
Biggest biotech IPO ever-and the CEO is 29!
Jim Cramer sits down with Axovant Sciences CEO Vivek Ramaswamy in the wake of its massive IPO on Thursday. Could it heat up your portfolio? 
Tags Tekmira Pharmaceuticals Corp Axovant Sciences Ltd Mad Money
From CNBC.com News
UPDATE 1-FDA panel backs approval of GSK asthma drug in adults
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and... 
Tags companyNews
From Reuters: Company News
FDA panel backs approval of GSK asthma drug in adults
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug for severe asthma in patients aged 18 and older. 
Tags companyNews
From Reuters: Company News
The Stock Whisper Of The Day: GSK
Hot Stock of the Day: GSK. 
Tags Stocks / Equities
From Blogs - TalkMarkets
China graft probes a tough tonic as pharma margins bounce
SHANGHAI, June 11 (Reuters) - Sales growth is picking up speed at Chinese drugs firms, and margins are widening, in a sign that the world's second-largest pharmaceuticals market may be rebounding from... 
Tags companyNews
From Reuters: Company News
Hedge Funds Buying Biotech IPO Operated By Ex-Fund Manager
Axovant Sciences (NASDAQ: AXON) is a late-stage biotech company focused on development of an Alzheimer’s therapy acquired from ... 
Tags Benzinga AXON Axovant sciences
From Benzinga
PRESS DIGEST- British Business - June 10
The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
5 New Stocks On Deck — Including Wingstop
 
Tags NYSE:WFC NYSE:EVR NASDAQ:DTEA
From InvestorPlace
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.